Han Liang Selected Research

Biomarkers (Surrogate Marker)

1/2022	Convergent Usage of Amino Acids in Human Cancers as A Reversed Process of Tissue Development.
1/2022	Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
1/2020	Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy.
8/2019	Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas.
1/2018	A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis.
1/2018	Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance.
12/2017	Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer.
1/2017	Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
10/2015	The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
9/2015	TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han Liang Research Topics

Disease

150	Neoplasms (Cancer) 03/2022 - 01/2002
110	Stomach Neoplasms (Stomach Cancer) 06/2022 - 04/2003
45	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2006
30	Lymphatic Metastasis 11/2021 - 01/2002
13	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2012
10	Carcinoma (Carcinomatosis) 01/2021 - 08/2004
7	Carcinogenesis 12/2021 - 10/2013
6	Adenocarcinoma 04/2021 - 01/2002
5	Colonic Neoplasms (Colon Cancer) 01/2014 - 08/2004
4	Endometrial Neoplasms (Endometrial Cancer) 08/2017 - 07/2011
3	Triple Negative Breast Neoplasms 01/2022 - 02/2016
3	Infections 01/2022 - 05/2012
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2015
3	Leukemia 05/2018 - 01/2015
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2014 - 06/2012
3	Hyperthermia 05/2008 - 08/2004
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
2	Wounds and Injuries (Trauma) 02/2020 - 04/2003
2	Kidney Neoplasms (Kidney Cancer) 01/2020 - 10/2017
2	Lung Neoplasms (Lung Cancer) 08/2019 - 01/2019
2	Genomic Instability 08/2019 - 05/2015
2	Hypoxia (Hypoxemia) 01/2019 - 01/2013
2	Lymphoma (Lymphomas) 04/2018 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 08/2017
2	Disease Progression 11/2017 - 06/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2017 - 01/2016
2	Peritoneal Neoplasms 01/2016 - 04/2003
2	Inflammation (Inflammations) 04/2015 - 02/2013
2	Hemorrhage 02/2013 - 03/2012
2	Rectal Neoplasms (Rectal Cancer) 08/2007 - 01/2002

Drug/Important Bio-Agent (IBA)

38	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2010
19	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2012
18	Messenger RNA (mRNA)IBA 11/2020 - 11/2010
16	RNA (Ribonucleic Acid)IBA 11/2021 - 05/2012
15	Pharmaceutical PreparationsIBA 03/2022 - 09/2015
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2014
12	Biological ProductsIBA 01/2021 - 09/2007
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2014
8	ProteomeIBA 01/2022 - 05/2014
8	Long Noncoding RNAIBA 12/2018 - 09/2015
7	immune RNA (I-RNA)IBA 01/2022 - 10/2015
5	Phosphotransferases (Kinase)IBA 01/2022 - 10/2012
5	Small Interfering RNA (siRNA)IBA 01/2020 - 11/2012
5	Indicators and Reagents (Reagents)IBA 02/2015 - 11/2009
4	NucleotidesIBA 12/2019 - 01/2018
4	hydrogen sulfite (bisulfite)IBA 01/2015 - 01/2014
4	Cadherins (E-Cadherin)IBA 03/2014 - 08/2004
3	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 02/2014
3	AntigensIBA 01/2020 - 01/2018
3	CateninsIBA 01/2020 - 03/2014
3	Inosine FDA Link 01/2018 - 10/2015
3	Adenosine (Adenocard)FDA LinkGeneric 01/2018 - 10/2015
3	Imatinib Mesylate (Gleevec)FDA Link 11/2017 - 06/2012
3	Transcription Factors (Transcription Factor)IBA 10/2017 - 08/2011
2	Amino Acids FDA Link 01/2022 - 10/2018
2	SaltsIBA 01/2022 - 12/2015
2	Phenobarbital (Luminal)FDA Link 01/2021 - 05/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2014
2	Capecitabine (Xeloda)FDA Link 01/2021 - 02/2014
2	EnzymesIBA 03/2020 - 01/2020
2	AntibodiesIBA 01/2020 - 05/2014
2	ChromatinIBA 01/2020 - 01/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 12/2017
2	Tyrosine Kinase InhibitorsIBA 05/2018 - 04/2014
2	Histone MethyltransferasesIBA 04/2018 - 04/2015
2	Deubiquitinating EnzymesIBA 04/2018 - 01/2018
2	Serum AlbuminIBA 01/2018 - 02/2011
2	UbiquitinIBA 01/2018 - 12/2017
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 04/2014
2	TeaIBA 12/2015 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 11/2015 - 12/2010
2	SolutionsIBA 04/2015 - 04/2003
2	LigandsIBA 01/2015 - 11/2009
2	Vascular Endothelial Growth Factor DIBA 01/2014 - 11/2009
2	CytokinesIBA 12/2013 - 11/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2012 - 07/2011
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2007 - 04/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	Cyclic PeptidesIBA 01/2022
1	VaccinesIBA 01/2022

Therapy/Procedure

62	Gastrectomy 07/2021 - 11/2007
40	Lymph Node Excision (Lymph Node Dissection) 11/2021 - 07/2007
33	Therapeutics 06/2022 - 01/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
7	Immunotherapy 01/2021 - 08/2017
5	Adjuvant Chemotherapy 01/2021 - 09/2007
4	Operative Surgical Procedures 05/2018 - 10/2010
3	Neoadjuvant Therapy 01/2021 - 01/2020
3	Hyperthermic Intraperitoneal Chemotherapy 12/2020 - 02/2012
3	Length of Stay 12/2020 - 06/2011
3	Cytoreduction Surgical Procedures 08/2016 - 02/2010
3	Blood Transfusion (Blood Transfusions) 01/2016 - 03/2006
2	Operative Time 03/2013 - 06/2011
2	Aftercare (After-Treatment) 05/2008 - 08/2007
2	Radiotherapy 05/2008 - 08/2007
1	Fecal Microbiota Transplantation 01/2022